Precision Biologics along with Dr Christina Annunziata, MD, PhD, from the NCI are presenting at the AACR Annual Meeting
The neoantigen-targeting antibody NEO-201 enhances NK cell-dependent killing of tumor cells through blockade of the...
The neoantigen-targeting antibody NEO-201 enhances NK cell-dependent killing of tumor cells through blockade of the...
Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas VIEW...
Dr. Philip Arlen to Speak at Immunotherapy Progress and Clinical Treatments December 5-7, 2017 in San...
Dr. Philip Arlen to Speak at World Vaccine Congress Europe Topic: Targeting cancer neoantigens: A promising source...
Dr. Philip Arlen to Speak at Immuno-Oncology Summit - The Summit will return to Boston on...
Dr. Philip Arlen to Speak at ASCO Annual Meeting - June 2-6, 2017 | McCormick Place...
May 1-5, 2017 Seaport World Trade Center Boston, MA FOR MORE INFORMATION LISTEN TO THE PODCAST
Monoclonal Antibodies Targeting Novel Immunogenic Neo-Epitopes for the Treatment of Solid Tumors May 2-4, 2017, Philadelphia Marriott...
Rockville, MD, April 2, 2017 - Precision-Biologics Inc.
Dr. Philip Arlen to Speak at Immuno-Oncology Breakthroughs - Novel Cancer Therapies at the Noblecon...